‪#‎SSc16‬ – Exclusive Interview with Pierre Broqua and Yannick Allanore, Inventiva

Recent Posts

• Cool Comedy, Hot Cuisine raises $1.3M+ for scleroderma research
• CAL101 treatment for scarring safe, well tolerated in Phase 1 trial
• Low ‘good’ cholesterol levels linked to more severe SSc-ILD
• Chest CT scan before transplant may predict survival after: Study
• SRF announces lineup for Cool Comedy, Hot Cuisine fundraiser
• Immune system’s toll-like receptor 8 may be SSc therapeutic target
• Certa’s SSc treatment candidate FT011 now known as asengeprast
• Antibodies vary by race, but don’t explain differences in scleroderma
• Profervia granted FDA orphan drug status as treatment for SSc
• Blood TSLP protein linked to greater risk of digital ulcers in SSc: Study